Skip to content

EV / sales at other companies

Eli Lilly logo
Eli LillyLLY
11.9×-4.0×
Hims & Hers Health logo
Hims & Hers HealthHIMS
-1.6×
The Beachbody Company logo
The Beachbody CompanyBODI
0.3×+0.1×
Omada Health, Inc. Common Stock logo
Omada Health, Inc. Common StockOMDA
3.3×
Herbalife logo
HerbalifeHLF
0.6×0.0×
Lifevantage Corporation logo
Lifevantage CorporationLFVN
0.3×-0.5×

Other financials

Income statement

See full
Revenue$168.3M-9.8%
Gross profit$118.7M-10.7%
Operating income-$30.4M-50.7%
Net income-$52.0M+28.4%
EPS (diluted)-$5.20-471%

Balance sheet

See full
Cash & equivalents$120.9M-48.9%
Total debt$468.2M-71.7%
Total equity$265.6M+122%
Total assets$881.1M+26.4%

Cash flow

See full
Operating cash flow-$33.5M-324%
CapEx$6.0K
Free cash flow$8.4M

Valuation

See full
Market cap$159.78M-95.5%
Enterprise value$507.1M-87.1%
P/S0.3×+0.2×

Profitability

See full
Gross margin71%+5.5pp
Operating margin-34.5%-37.5pp
Net margin-23.2%-8.6pp
FCF margin-0.7%-3.3pp

Returns & leverage

See full
Return on equity268.4%
Debt / equity1.8×
Current ratio1.2×+1.0×

Where this comes from

Calculated from WW International, Inc.’s reported figures.

Based on the most recent quarter.

The official record: WW International, Inc.’s 10-Q, filed November 6, 2025, on SEC EDGAR. View the filing →

Ask your AI about WW International, Inc.'s ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is WW International, Inc.'s EV / sales?
WW International, Inc. (WW) reported EV / sales of 1× in Q3 2025.
How has WW International, Inc.'s EV / sales changed year-over-year?
WW International, Inc.'s EV / sales decreased by 44.5% year-over-year, from 1.9× to 1×.
What is the long-term trend for WW International, Inc.'s EV / sales?
Over 4 years (2020 to 2024), WW International, Inc.'s EV / sales has grown at a -9.8% compound annual growth rate (CAGR), from 3× to 1.9×.
What does EV / sales mean?
Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.